GALNT2 and coronary artery disorder: The average age of the participants with GALNT2 gene promoter hypermethylation is 62.10±8.21, statistically significantly higher than that of the participants without hypermethylation which is 57.28±9.87 (P = 0.004; P* = 0.008); in the former group, 75.4% of the participants have CHD, significantly higher than 50% in the latter group (P = 0.003; P* = 0.008).